Search
Sitamaquine
go.drugbank.com/drugs/DB04909InvestigationalSitamaquine (WR-6026) is an orally active 8-aminoquinoline analog in development by the Walter Reed Army Institute, in collaboration with GlaxoSmithKline (formerly SmithKline Beecham), for the potential
Prostaglandin E synthase 3
go.drugbank.com/bio_entities/BE0002480TargetHumansMolecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory
Synonyms: Progesterone receptor complex p23SLAM family member 7
go.drugbank.com/bio_entities/BE0003492TargetHumansSelf-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family.
Synonyms: CD2-like receptor-activating cytotoxic cellsTW-37
go.drugbank.com/drugs/DB17059ExperimentalTW-37 is a small-molecule inhibitor of Bcl-2 investigated for its anti-cancer properties.[A253157]
Crefmirlimab
go.drugbank.com/drugs/DB17577InvestigationalCrefmirlimab is an anti-human CD8 probe targeting the CD8 antigen, for the diagnosis of various cancers.
BHT-3034
go.drugbank.com/drugs/DB18045ExperimentalBHT-3034 is a DNA plasmid vaccine immunotherapy under investigation for the treatment of myasthenia gravis.[L48086]
XEN-D0501
go.drugbank.com/drugs/DB18673InvestigationalXEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia.
Daphnetin
go.drugbank.com/drugs/DB18965InvestigationalDaphnetin is under investigation in clinical trial NCT06329167 (Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery).
Radavirsen
go.drugbank.com/drugs/DB15332InvestigationalRadavirsen is under investigation in clinical trial NCT01375985 (Safety Study of Single Administration Intravenous Treatment for Influenza).
Norleucine
go.drugbank.com/drugs/DB15458InvestigationalNorleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).